Login to Your Account



Avillion’s co-development model draws Pfizer into first deal

By Nuala Moran
Staff Writer

Friday, January 17, 2014

LONDON – After a year of spreading the word and working to convince people of the attractions of its finance and risk-sharing model, Avillion Group Partners LLP has signed up Pfizer Inc. as the first partner for its Phase III co-development scheme.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription